DK0625166T3 - Sulfaterede polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater deraf - Google Patents

Sulfaterede polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater deraf

Info

Publication number
DK0625166T3
DK0625166T3 DK93904154.7T DK93904154T DK0625166T3 DK 0625166 T3 DK0625166 T3 DK 0625166T3 DK 93904154 T DK93904154 T DK 93904154T DK 0625166 T3 DK0625166 T3 DK 0625166T3
Authority
DK
Denmark
Prior art keywords
processes
preparation
pharmaceutical compositions
sulfated polysaccharides
daltons
Prior art date
Application number
DK93904154.7T
Other languages
Danish (da)
English (en)
Inventor
Andre Uzan
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of DK0625166T3 publication Critical patent/DK0625166T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0041—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate characterised by the choice of an antithrombatic agent other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK93904154.7T 1992-02-07 1993-02-04 Sulfaterede polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater deraf DK0625166T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201383A FR2687158B1 (fr) 1992-02-07 1992-02-07 Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.

Publications (1)

Publication Number Publication Date
DK0625166T3 true DK0625166T3 (da) 1998-02-02

Family

ID=9426428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93904154.7T DK0625166T3 (da) 1992-02-07 1993-02-04 Sulfaterede polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater deraf

Country Status (17)

Country Link
EP (1) EP0625166B1 (de)
JP (1) JP3218039B2 (de)
KR (1) KR950700334A (de)
AT (1) ATE157991T1 (de)
AU (1) AU671817B2 (de)
CA (1) CA2126241C (de)
DE (1) DE69313826T2 (de)
DK (1) DK0625166T3 (de)
ES (1) ES2109478T3 (de)
FI (1) FI106034B (de)
FR (1) FR2687158B1 (de)
GR (1) GR3024695T3 (de)
HU (1) HU214327B (de)
MX (1) MX9300584A (de)
NO (1) NO307466B1 (de)
NZ (1) NZ249165A (de)
WO (1) WO1993016112A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
EP0735050B1 (de) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Zusammensetzung zur Hemmung der Thromboseentstehung
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
US6075013A (en) * 1997-06-06 2000-06-13 Hamilton Civic Hospitals Research Development Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP2404939A3 (de) 2006-05-25 2012-03-21 Momenta Pharmaceuticals, Inc. Heparinzusammensetzung mit geringem Molekulargewicht und Anwendungen dafür
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
CA3020369C (en) * 2010-09-14 2019-11-26 University Of Miyazaki High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945595A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Verfahren zur herstellung von niedermolekularem heparin bzw. seinen salzen
FR2622450B1 (fr) * 1987-11-03 1991-02-22 Sanofi Sa Association heparine/dermatane sulfate
EP0337327A1 (de) * 1988-04-09 1989-10-18 Bioiberica, S.A. Verfahren zur Herstellung von neuen Oligosaccharid-Fragmenten durch kontrollierte chemische Depolymerisation von Heparin
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2675806B1 (fr) * 1991-04-23 1994-06-10 Rhone Poulenc Rorer Sa Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.

Also Published As

Publication number Publication date
NO307466B1 (no) 2000-04-10
FR2687158A1 (fr) 1993-08-13
AU3505193A (en) 1993-09-03
FR2687158B1 (fr) 1995-06-30
DE69313826D1 (de) 1997-10-16
ES2109478T3 (es) 1998-01-16
FI106034B (fi) 2000-11-15
DE69313826T2 (de) 1998-02-12
NZ249165A (en) 1996-01-26
CA2126241C (fr) 2004-06-22
HU214327B (hu) 1998-03-02
HUT67878A (en) 1995-05-29
ATE157991T1 (de) 1997-09-15
AU671817B2 (en) 1996-09-12
GR3024695T3 (en) 1997-12-31
MX9300584A (es) 1993-08-01
NO942897D0 (de) 1994-08-04
NO942897L (no) 1994-08-04
HU9401994D0 (en) 1994-09-28
KR950700334A (ko) 1995-01-16
JPH07503496A (ja) 1995-04-13
EP0625166A1 (de) 1994-11-23
EP0625166B1 (de) 1997-09-10
WO1993016112A1 (fr) 1993-08-19
JP3218039B2 (ja) 2001-10-15
CA2126241A1 (fr) 1993-08-19
FI943642A (fi) 1994-08-05
FI943642A0 (fi) 1994-08-05

Similar Documents

Publication Publication Date Title
IL61201A (en) Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
AU563289B2 (en) Depolymerized and supersulfated heparin
DK0625166T3 (da) Sulfaterede polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater deraf
CA2023970A1 (en) Collagen compositions and methods for preparation thereof
NO973311D0 (no) Ikke-farmasöytisk polysakkaridkonjugat
IT8921066A0 (it) Composizioni polimeriche autoestinguenti.
IT8747630A0 (it) Derivati di dicloroanilina, composizioni farmaceutiche che li contengono e procedimento per produrli
DK0912613T3 (da) Syntetiske polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem
BR9100297A (pt) Derivados da pirazolina substituidos,processo para sua preparacao,composicao praguicida,processo para combater pragas e para a preparacao de composicoes
IT1238685B (it) Polisaccaridi ad azione immunomodulatrice da astragalus membranaceous e composizioni farmaceutiche che li contengono
DK0711302T3 (da) Byggeeblokke med carbamat-internukleosidbindinger og hidtil ukendte oligonukleotider afledt deraf
AU2617988A (en) Non-anticoagulant heparan sulfate, process for extraction from organs, and pharmaceutical compositions thereof
EP0435211A3 (en) Photo-curable, urethane-containing compositions
ZA95577B (en) Pharmaceutical compositions
NO943826D0 (no) Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede
IT9021332A0 (it) Expolimero ottenuto a partire da ceppi selezionati del genere bifidobacterium, suo procedimento di preparazione e composizioni farmaceutiche che lo contengono
FR2708855B1 (fr) Compositions pharmaceutiques immunoadjuvantes ou immunostimulantes.
IT1243921B (it) Derivati di selenofene, un procedimento per la loro preparazione e composizioni che li contengono.
IT8422898A0 (it) Derivati di 1,4-diidropiridina e composizioni farmaceutiche che licontengono.
IT8921562A0 (it) Composizioni polimeriche autoestinguenti.
IT8820226A0 (it) Fosfatidil n_acetil_l_serina, composizioni farmaceutiche che la contengono e processo per la sua preparazione.